SCHEMBL31157508

SCHEMBL31157508

CC(C)(C)OC(=O)N1CCC(n2cc(C(=O)O)c(=O)c3cc(Cl)c(N4Cc5cccnc5C4)nc32)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 1/20 0.41
▸ DPP4 P27487 6/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ FNTA P49354 2/20 0.38
▸ FNTB P49356 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ CHRM2 P08172 1/20 0.38
▸ DRD1 P21728 1/20 0.38
▸ GPR119 Q8TDV5 2/20 0.37
▸ NR3C1 P04150 2/20 0.37
▸ IDH1 O75874 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ SRC P12931 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31157482 0.88 FNTA (0.39) PIK3CGMEN1KMT2AFNTAFNTB
SCHEMBL31157459 0.84 DPP4 (0.43) PIK3CGDPP4KMT2ACHRM2DRD1
SCHEMBL31157573 0.76 KDM4E (0.53) PIK3CGKDM4EALDH1A1MAPTHPGD
SCHEMBL31157466 0.76 GRM1 (0.36) PIK3CGDPP4POLBKDM4EALDH1A1
SCHEMBL30298089 0.75 PIK3CG (0.38) PIK3CGDPP4MEN1KMT2AKDM4E
SCHEMBL31157490 0.75 LMNA (0.39) PIK3CGMEN1KMT2AKDM4ETSHR
SCHEMBL31157507 0.75 PIK3CG (0.53) PIK3CGKDM4EALDH1A1MAPTHPGD
SCHEMBL31157532 0.74 LMNA (0.43) PIK3CGKDM4ETSHRNPSR1TDP1
SCHEMBL31157553 0.74 PIK3CG (0.51) PIK3CGKDM4EALDH1A1MAPTHPGD
SCHEMBL31157592 0.73 LMNA (0.37) PIK3CGKDM4ETSHRNPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376100-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1, 4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES Redona Therapeutics, Inc. 2024-11-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376100-A1 PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1, 4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES PAPSS1, OTUD7B, BRD7 PIK3CG 2909/4885DPP4 324/4885MEN1 3213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback